Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Neoplasm
and you are
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This pilot trial evaluates in vivo megestrol acetate (MA) modulation of steroidal receptors in advanced breast cancer.

Provided treatments

  • Drug: Megestrol Acetate 160Mg Tablet
  • Drug: Anastrozole 1Mg Tablet
  • Drug: Letrozole 2.5Mg Tablet
  • Drug: Exemestane 25 MG
  • Drug: Tamoxifen 20Mg Tablet
  • Drug: Fulvestrant 50Mg Solution for Injection
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03024580. The sponsor of the trial is Instituto Nacional de Cancer, Brazil and it is looking for 20 volunteers for the current phase.
Official trial title:
A Pilot Study Evaluating Megestrol Acetate Modulation in Advanced Breast Cancer With Positive Hormonal Receptor